Argos Therapeutics, Inc.: Financial Highlights
- December 2017
- 73 pages
- ID: 5286343
Pursuant to the agreement, Lummy HK will pay Argos royalties on net sales and up to an aggregate of $## million upon the achievement of manufacturing, regulatory and commercial milestones.
If Medinet exercises the sale option, it will pay Argos $## million, as well as royalties on net sales at a rate to be negotiated until the later of the expiration of the licensed patent rights in Japan and the twelfth anniversary of the first commercial sale in Japan.
Summary
Table of Contents
Search Inside
Argos Therapeutics, Inc. - M&A, Partnerships & Alliances and Investment Report
Brief
Marketline's Argos Therapeutics, Inc. Mergers & Acquisitions, Alliances & Collaborations and Investments analysis includes business overview, comprehensive reports on M&A, divestments, capital raisings, venture capital investments, ownership and partnership deals undertaken by Argos Therapeutics, Incorporated since January2007.
Abstract
Marketline's Company Mergers & Acquisitions, Alliances & Agreements and Investments reports offer a exhaustive breakdown of the organic and inorganic growth activity undertaken by an institution to sustain its opposing advantage.
Key Findings
This analysis comprises Argos Therapeutics, Inc.'s contact details and business overview, figures&tables, a catalog of partners with their descriptions, contact details, investors and targets, a detailed financial analysis and legal advisors, transactions types, main deals by amount, exhaustive transactions analysis, where disclosed.
This analysis also covers comprehensive financial details for all mergers and acquisitions, private equity, public offering, venture financing, alliances and partnership and other transactions initiated by Argos Therapeutics, Incorporated. Theses analysis include data about target company financials, payment methods, sources of business financing, deal values, and advisors, where disclosed.
Overview
- Offers intelligence on Argos Therapeutics, Inc.'s M&A, important business deals, capital raising and private equity transactions.
- Several analysis of financial deals initiated by Argos Therapeutics, Incorporated and its subsidiaries since 2007.
- Data about top financial and legal advisors for Argos Therapeutics, Inc.'s financial agreements transactions.
-Financial transactions tables and charts encompassing deals by: values, volumes, types and geographical zones.
Purposes to acquire this study
- Retrieve complete corporate deals data with mergers and acquisition charts and graphs, private equity, and alliances/partnerships and.
- Build an independant judgement about Argos Therapeutics, Inc.'s development strategies through the organic and inorganic actions carried out since 2007.
- Follow your competitors' commercial model and growth plans.
Get Industry Insights. Simply.
- Latest reports & slideshows with insights from top research analysts
- 60 Million searchable statistics with tables, figures & datasets
- More than 25,000 trusted sources
- +1 718 618 4302
- Contact by email
The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.
Kate Merrick
Global Marketing Manager at
Eurotherm by Schneider Electric
We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.
Category Manager at
Ikea
ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.
Executive Director at
PwC Advisory
The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!
Scott Griffith
Vice President Marketing at
Maurice Sporting Goods
The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research
Jessica P Huffman
Research Associate at
American Transportation Research Institute
Excellent customer service. Very responsive and fast.
Director, Corporate Strategy at
Ingredion
I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.
Mariana Mendoza
Global Platform Senior Manager at
Whirlpool Corporation
Thanks! I like what you've provided and will certainly come back if I need to do further research works.
Bee Hin Png
CEO at
LDR Pte Ltd
The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.
Kate Merrick
Global Marketing Manager at
Eurotherm by Schneider Electric
-
How we can help
- I am not sure if the report I am interested in will fulfill my needs. Can you help me?
- Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
- We buy reports often - can ReportLinker get me any benefits?
- Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
- I have had negative experiences with market research reports before. How can you avoid this from happening again?
We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.
-
Report Delivery
- How and when I will receive my Report?
- Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
-
Payment conditions
- What payment methods do you accept?
-
- Credit card : VISA, American Express, Mastercard, or
- You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
- You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
- What are ReportLinker’s Payment Terms?
- All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
- Are Taxes and duties included?
- All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
- I’m not satisfied. Can I be refunded?
- No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
-
User license
- The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Summit Therapeutics Plc: Financial Highlights
- $ 350
- Company report
- February 2018
- by MarketLine
Summit Therapeutics Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportSummaryMarketline’s Summit Therapeutics Plc Mergers & Acquisitions (M&A), Partnerships & Alliances ...
Gedeon Richter Plc: Financial Highlights
- $ 350
- Company report
- February 2018
- by MarketLine
Gedeon Richter Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportSummaryMarketline’s Gedeon Richter Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments ...
Allergan plc: Financial Highlights
- $ 350
- Company report
- February 2018
- by MarketLine
Allergan plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportSummaryMarketline’s Allergan plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report ...
Meda AB: Financial Highlights $ 350 February 2018
Mylan N.V.: Financial Highlights $ 350 February 2018
Mitsubishi Tanabe Pharma Corporation: Fina ... $ 350 February 2018
Astellas Pharma Inc.: Financial Highlights $ 350 February 2018
Ocera Therapeutics Inc: Financial Highligh ... $ 350 February 2018
Aratana Therapeutics, Inc.: Financial High ... $ 350 February 2018
Mylan Laboratories Limited: Financial High ... $ 350 February 2018
More Reports:
Therapy in the United States (1266)
Therapy in the World (3411)
Therapy in Japan (225)
Therapy in North America (207)
Therapy in Germany (178)
Therapy in Spain (164)
Therapy in China (151)
Therapy in France (151)
More Reports:
Therapy in the United States (5803)
Therapy in the World (1523)
Therapy in Australia (799)
Therapy in Canada (788)
Therapy in India (566)
Therapy in Europe (562)
Therapy in Oceania (432)
Therapy in China (376)
ref:plp2017
Reportlinker.com © Copyright 2018. All rights reserved.